BioStock: Chordate’s study results published in Neurology

Chordate Medical’s results from the migraine study PM007 with Ozilia have now been published in the highly ranked journal Neurology. The publication has been eagerly awaited by both shareholders and other stakeholders, leading to a stock price increase of over 90 percent. According to CEO Anders Weilandt, the scientific article will play a central role in the company’s ongoing marketing strategy and exit process.

Read the full article at biostock.se:

https://www.biostock.se/en/2025/01/chordates-study-results-published-in-neurology/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se